The primary aim of this analysis was to explore whether proposed physical and psychological function measures (depression, anxiety, fatigue, and physical functioning) and mechanistic biomarkers (BDNF, HOMA2-IR, and CRP) mediated intervention effects on cognition. The gene discussed is CRP; the disease is Anxiety.